(GENI) Generic Sweden publ - Ratings and Ratios
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0001790791
GENI: Messaging Services, Digital Communication Platforms, IT Consulting
Generic Sweden publ AB, traded as GENI on the Stockholm stock exchange, is a technology-driven entity that specializes in providing comprehensive messaging solutions, catering to a wide range of applications and use cases. This encompasses not only traditional messaging services but also more advanced communication tools, all designed to facilitate seamless interaction and data exchange. By leveraging its expertise in digital communication, the company aims to bridge gaps and enhance connectivity across various platforms and industries.
Established in 1993, Generic Sweden publ AB has its headquarters in Stockholm, Sweden, positioning it strategically within the European technology landscape. Over the years, the company has developed a robust platform for digital communication services, addressing the evolving needs of its clientele. This platform serves as a backbone for numerous applications, enabling efficient, secure, and reliable communication. With a strong foundation in IT, Generic Sweden publ AB continues to innovate and expand its service portfolio, aligning with the latest trends and technological advancements in the field.
As a publicly traded company, Generic Sweden publ AB is listed under the ISIN code SE0001790791, with its stock classified as common stock. The company operates within the GICS Sub Industry of IT Consulting & Other Services, a sector that is increasingly crucial in today's digital economy. This classification reflects the company's core business activities, which are centered around providing expert IT consulting services and other related offerings. Through its website, https://www.generic.se, the company offers insights into its mission, services, and vision for the future of digital communication.
Additional Sources for GENI Stock
GENI Stock Overview
| Market Cap in USD | 68m |
| Sector | Technology |
| Industry | Software - Application |
| GiC Sub-Industry | IT Consulting & Other Services |
| IPO / Inception |
GENI Stock Ratings
| Growth 5y | 53.0% |
| Fundamental | 62.4% |
| Dividend | 71.3% |
| Rel. Strength Industry | 15.8 |
| Analysts | - |
| Fair Price Momentum | 56.50 SEK |
| Fair Price DCF | 16.69 SEK |
GENI Dividends
| Dividend Yield 12m | 2.80% |
| Yield on Cost 5y | 7.63% |
| Annual Growth 5y | 37.97% |
| Payout Consistency | 98.0% |
GENI Growth Ratios
| Growth Correlation 3m | 76.9% |
| Growth Correlation 12m | 45.2% |
| Growth Correlation 5y | 30.6% |
| CAGR 5y | 24.54% |
| CAGR/Max DD 5y | 0.33 |
| Sharpe Ratio 12m | 0.95 |
| Alpha | 22.87 |
| Beta | 0.66 |
| Volatility | 73.68% |
| Current Volume | 12.8k |
| Average Volume 20d | 36.1k |
As of February 23, 2025, the stock is trading at SEK 59.20 with a total of 12,807 shares traded.
Over the past week, the price has changed by -3.90%, over one month by +2.07%, over three months by +21.06% and over the past year by +37.41%.
Yes, based on ValueRay Fundamental Analyses, Generic Sweden publ (ST:GENI) is currently (February 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 62.40 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GENI as of February 2025 is 56.50. This means that GENI is currently overvalued and has a potential downside of -4.56%.
Generic Sweden publ has no consensus analysts rating.
According to ValueRays Forecast Model, GENI Generic Sweden publ will be worth about 66.3 in February 2026. The stock is currently trading at 59.20. This means that the stock has a potential upside of +11.93%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 5.6 | -90.6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 66.3 | 11.9% |